Japan’s AGC joins project to develop coronavirus DNA vaccine

TOKYO — Japanese chemical and materials maker AGC said Thursday it has teamed up with an Osaka University-affiliated biotechnology company to help produce a coronavirus vaccine that offers a great mass-manufacturing advantage.

The DNA vaccine project is a collaboration between biotech venture AnGes and Takara Bio, which will handle most of the production work.

Seattle-based AGC Biologics, a subsidiary of AGC, will supply an intermediate material. The vaccine is expected to enter clinical trials as early as this summer.

Takara Bio looks to manufacture about 200,000 doses in a year. Unlike standard vaccines, which use live or inactivated pathogens to

Read More

Singapore’s Temasek joins Facebook-backed Libra currency

SINGAPORE — Singapore state investment firm Temasek Holdings has joined Facebook’s Libra cryptocurrency project, the Libra Association announced Thursday.

A major boost for the Swiss-based Libra Association, Temasek said it was joining the non-profit independent organization formed to facilitate the development of the cryptocurrency to explore its advanced use.

“Blockchain technology can play a transformative role in payments networks by enhancing cost efficiencies, creating new business opportunities and accelerating financial inclusion,” Chia Song Hwee, deputy Chief Executive Officer of Temasek International, said in a statement.

“Our participation in the Libra Association as a member will allow us to contribute towards

Read More